In the intervention group, questionnaires were distributed prior to lectures provided as part of the intervention; in the control group we supervised self-completion at baseline, and distributed questionnaires at follow-up for self-completion and return to a central location.
The following measures will be completed at baseline and on completion of the study when the health professional has completed delivery of the psychosocial Intervention.
Among all employed axSpA RS patients who were required to answer WPS Q2 through Q4, the completion rates at baseline were also high, with only two (0.9%) missing answers for Q2 and three (1.3%) missing answers for Q3 and Q4.
Participants will receive a self-completion questionnaire at baseline, three, six and 12 months post consultation to gather further data on pain, disability and psychological status.
Data will be obtained from four main sources: the patient self-completion questionnaires at baseline, 6 weeks and 6 months after randomisation; primary care patient records; patient records at the physiotherapy services; and records kept as part of the trial detailing length of consultation, grade of staff, and amount of non-contact time.
Patients completed the IPSS at baseline (after completion of the placebo run-in period) and at every 13-week clinic visit thereafter during the study treatment period.
Patients completed the PPSM at baseline (after completion of the placebo run-in period) and at every 13-week clinic visit thereafter during the study treatment period.
Participants in both arms of the study were asked to fill in a self-completion questionnaire (SCQ) at baseline and after six and twelve months.
The median tumor size in the breast was 26 mm, 13 mm, and 10 mm at baseline, completion of AC, and completion of SD chemotherapy, respectively.
Patients completed the PRO measures at baseline (after completion of the placebo run-in period) and at every 13-week clinic visit thereafter for the duration of the study period.
While most patients completed the FACT-P questionnaire at baseline, the completion rates decreased at later time points due to attrition associated with disease progression, particularly in the placebo group.
